Hanmi Pharmaceutical's Countmate targets the vial-based medication packaging market in Canada and the US. Hanmi ...
23h
GlobalData on MSNHanmi Pharmaceutical unveils automated vial dispensing machineHanmi Pharmaceutical has launched Countmate, a fully automated vial dispensing machine designed to meet the specific needs of ...
The Food and Drug Administration (FDA) has expanded the labeling for Izervayâ„¢ (avacincaptad pegol intravitreal solution) to include longer-term ...
SEOUL, South Korea, Feb. 13, 2025 /CNW/ -- Hanmi Pharmaceutical's Global Business Headquarters Overseas Sales Team is making ...
Stifel Nicolaus analyst Bradley Canino maintained a Buy rating on Syndax Pharmaceuticals (SNDX – Research Report) today and set a price target of $42.00. The company’s shares closed yesterday ...
The Food and Drug Administration (FDA) has approved 2 additional vial sizes of Niktimvo â„¢ (axatilimab-csfr), 9mg/0.18mL and 22mg/0.44mL, in addition to the 50mg/mL size. Niktimvo, a colony stimulating ...
Sealian is suitable for all routes of administration (parenteral, oral and nasal) and is available for all glass types in vial sizes ranging from 3ml to 500ml in both clear and amber glass. At ...
The CELESTIAL-301 trial evaluating SynKIR-310, a novel CAR T-cell therapy, has dosed its first patient with relapsed/refractory B-cell non-Hodgkin lymphoma. The first patient with relapsed/refractory ...
A man in his 30s has been found dead inside a house in Swindon following the discovery of an 'unidentified vial of liquid'. Emergency services rushed to a house on Collett Avenue at around 4 ...
The treatment was approved in 2024 for chronic graft-vs-host disease after failure of at least 2 prior lines of systemic therapy in patients weighing at least 40kg. The Food and Drug ...
Incyte, a global biopharmaceutical company on a mission to Solve On, and Syndax Pharmaceuticals, a commercial-stage biopharmaceutical company, announced that the US Food and Drug Administration (FDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results